Last mentioned: Mar 19, 2026
Scheduled Re-evaluation
NICE appraisal committee is set to meet for a second round of evidence review.
Module 3 Report Released
The inquiry sets out its findings on the impact of the pandemic on the NHS and patients.
NHS Impact Probe
The inquiry sets out detailed evidence regarding the pandemic's impact on NHS patients and staff.
Current Report
Figures confirm a sustained downward trend, signaling a potential end to the backlog crisis.
Public Campaign Launch
Bereaved family launches a national campaign imploring the NHS to reconsider the approval.
NICE Initial Review
NICE issues a preliminary recommendation against the drug due to cost-effectiveness concerns.
FDA Approval
The treatment receives accelerated approval in the United States for aggressive cancer types.
First Major Decline
The first statistically significant monthly drop in total waiting list volume is recorded.
Recovery Plan Update
Government announces additional £2.5B for diagnostic technology and surgical hubs.
Module 3 Hearings Begin
Public hearings for Module 3 commence, focusing on the impact on healthcare systems.
Module 3 Hearings Begin
Public hearings start for the module focused on the impact on healthcare systems.
Peak Backlog
NHS waiting list hits a record high of approximately 7.77 million patients.
Inquiry Established
The UK COVID-19 Inquiry is formally established to examine the UK's response to the pandemic.
Inquiry Established
The UK COVID-19 Inquiry is formally set up to examine the UK's response to the pandemic.
First National Lockdown
UK government imposes stay-at-home orders, significantly impacting NHS service delivery.
The UK’s public inquiry into the COVID-19 pandemic has entered a critical phase, examining the systemic impact on the National Health Service (NHS) and patient outcomes. This module scrutinizes healthcare capacity, the management of non-COVID services, and the effectiveness of medical interventions during the crisis.
The UK COVID-19 Inquiry's Module 3 report, released March 19, 2026, provides a definitive assessment of the pandemic's impact on the NHS and patient care. The findings highlight systemic failures, workforce trauma, and the long-term consequences of treatment delays across the healthcare system.
New data released in March 2026 shows a sustained decline in the NHS elective care waiting list, marking a significant milestone in the post-pandemic recovery. The figures suggest that structural reforms, including surgical hubs and digital triage, are finally outpacing new referrals.
A bereaved family's public campaign has reignited a national debate over the NHS's drug appraisal process for aggressive cancers. The movement highlights the growing tension between fiscal cost-effectiveness and the urgent need for life-extending therapies already available in other markets.
The NHS is facing a critical failure in cancer care delivery, with a growing number of patients waiting over 104 days for treatment. This systemic breach of performance standards highlights severe diagnostic bottlenecks and capacity constraints across the UK health system.